4,686 Shares of IDEX Corporation $IEX Purchased by North Star Investment Management Corp.

North Star Investment Management Corp. purchased a new stake in shares of IDEX Corporation (NYSE:IEX – Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 4,686 shares of the industrial products company’s stock, valued at approximately $1,068,000.

Other large investors have also recently made changes to their positions in the company. Burkett Financial Services LLC purchased a new position in shares of IDEX during the third quarter valued at approximately $27,000. Optiver Holding B.V. bought a new position in IDEX during the first quarter valued at approximately $27,000. Quantbot Technologies LP purchased a new stake in IDEX in the second quarter worth approximately $33,000. Elevation Wealth Partners LLC boosted its holdings in IDEX by 42.7% in the third quarter. Elevation Wealth Partners LLC now owns 147 shares of the industrial products company’s stock worth $34,000 after purchasing an additional 44 shares during the last quarter. Finally, SJS Investment Consulting Inc. grew its position in IDEX by 104.1% in the 1st quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after purchasing an additional 76 shares during the period. 97.96% of the stock is currently owned by institutional investors.

IDEX Stock Performance

Shares of NYSE IEX opened at $239.67 on Friday. The firm has a 50 day moving average of $230.11 and a 200 day moving average of $215.72. The company has a current ratio of 2.78, a quick ratio of 2.15 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $17.67 billion, a price-to-earnings ratio of 33.29, a price-to-earnings-growth ratio of 2.67 and a beta of 0.97. IDEX Corporation has a 12-month low of $160.60 and a 12-month high of $243.80.

IDEX (NYSE:IEX – Get Free Report) last announced its earnings results on Wednesday, October 28th. The industrial products company reported $2.33 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.09. IDEX had a net margin of 14.65% and a return on equity of 16.18%. The business had revenue of $951.70 million during the quarter, compared to analysts’ expectations of $934.36 million. During the same period in the prior year, the company earned $2.03 earnings per share. The firm’s revenue was up 8.3% on a year-over-year basis. On average, research analysts anticipate that IDEX Corporation will post 8.92 earnings per share for the current year.

IDEX Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Friday, October 2nd were paid a $0.73 dividend. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Friday, October 2nd. IDEX’s dividend payout ratio is 42.01%.

Key IDEX News

Here are the key news stories impacting IDEX this week:

  • Positive Sentiment: Q3 results exceeded expectations: IDEX reported quarterly revenue of $951.7 million, up 8.3% year over year and above the $934.4 million consensus estimate. Adjusted EPS of $2.33 also topped expectations of approximately $2.24 and rose from $2.03 in the prior-year quarter. IDEX Q3 Earnings and Revenues Beat Estimates
  • Positive Sentiment: Outlook was raised: Management forecast 2026 organic sales growth of 6.5% to 6.8% and adjusted diluted EPS of $8.91 to $8.96, supported by momentum in advantaged markets. Third-quarter orders increased 13% year over year to $991.2 million, suggesting healthy demand. IDEX Raises 2026 Outlook
  • Positive Sentiment: Operating performance remained solid: Health & Science Technologies sales rose 14%, while operating cash flow increased to $239.5 million from $203.5 million. IDEX also returned $129 million to shareholders through dividends and share repurchases. IDEX Posts Record Third-Quarter Sales
  • Positive Sentiment: Analysts remain constructive: Stifel raised its price target from $267 to $273 and maintained a “buy” rating, implying additional upside from current trading levels. Stifel Raises IDEX Price Target
  • Neutral Sentiment: RBC trimmed its price target modestly from $285 to $283 but retained an “outperform” rating, indicating that its valuation view remains favorable despite the adjustment. RBC Trims IDEX Price Target
  • Negative Sentiment: Recent insider activity cited in the coverage showed selling by company executives and no open-market insider purchases over the past six months, a modest cautionary signal for investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Weiss Ratings reiterated a “buy (b-)” rating on shares of IDEX in a research note on Wednesday. Argus raised their price target on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. DA Davidson set a $245.00 price objective on IDEX in a report on Thursday. Stifel Nicolaus lifted their price objective on IDEX from $267.00 to $273.00 and gave the stock a “buy” rating in a report on Thursday. Finally, KeyCorp upgraded IDEX to a “hold” rating in a research report on Monday, October 12th. Nine equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, IDEX currently has an average rating of “Moderate Buy” and an average price target of $263.64.

Read Our Latest Analysis on IDEX

Insider Activity at IDEX

In related news, CAO Lisa Anderson sold 385 shares of the firm’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total value of $91,857.15. Following the transaction, the chief accounting officer directly owned 4,327 shares of the company’s stock, valued at approximately $1,032,378.93. This trade represents a 8.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.50% of the stock is owned by company insiders.

IDEX Company Profile

(Free Report)

IDEX Corporation is an industrial manufacturing company headquartered in Lake Forest, Illinois. The company designs and produces engineered products and technologies used to move, control, measure and apply fluids, as well as equipment used in fire and safety applications.

IDEX operates through businesses serving fluid and metering technologies, health and science technologies, and fire and safety markets. Its products include pumps, valves, flow meters, compressors, dispensing equipment, precision fluidics components and systems, fire pumps, rescue tools and other specialized equipment.

The company serves a broad range of industries, including healthcare, life sciences, water and wastewater, chemical processing, energy, food and beverage, agriculture, industrial manufacturing and municipal fire protection.

Further Reading

Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).

Institutional Ownership by Quarter for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.